Tata Chemicals rose 1.79% to Rs 297.75 after Tata Sons purchased 0.87% stake of the chemical maker via bulk deal on the NSE.
On Wednesday (23 September), Tata Sons bought 22.10 lakh equity shares (0.87% equity) of Tata Chemicals at Rs 287.58 per share via bulk deal on the NSE.
As of 30 June 2020, Tata Sons held 28.51% stake in the company.
On a consolidated basis, the chemicals maker's net profit dropped 67.2% to Rs 74.15 crore on 9.13% decline in net sales to Rs 2,348.16 crore in Q1 June 2020 over Q1 June 2019.
Tata Chemicals is a global company with interests in businesses that focus on basic chemistry products, consumer and specialty products.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app